A pronounced increase of FABP5 was also observed in breast cancer, and molecular analyses showed a close correlation between the chaperone levels with activation of the epidermal growth factor receptor (EGFR) signalling pathway (Powell et al. 2015). Here, EGFR is linked to breast carcinoma.